Ala-Bcc-Ct013
ClinicalTrials.gov NCT03573401
Research payments
$1,437,822
Through program year 2024, $1,437,822 in research payments was reported against Ala-Bcc-Ct013, across 83 payments, paid by Biofrontera Bioscience GmbH.
- Paid by
- Biofrontera Bioscience GmbH
- ClinicalTrials.gov
- NCT03573401
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $412,307 | 45 |
| 2023 | Research | $659,202 | 24 |
| 2022 | Research | $366,313 | 14 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Michael Chapman Lebanon, NH Named on 18 payments
- Abel Torres Gainesville, FL Named on 9 payments
- Joel Cohen Greenwood Village, CO Named on 7 payments
- Sadra Jazayeri Phoenix, AZ Named on 7 payments
- Sherrif Ibrahim Victor, NY Named on 6 payments
- Edward Lain Pflugerville, TX Named on 6 payments
- Carl Hanke Indianapolis, IN Named on 4 payments
- David Ozog Detroit, MI Named on 4 payments
- Vivian Laquer Fountain Valley, CA Named on 4 payments
- John Tu Rochester, NY Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.